Abstract Bioengineered heparin is being investigated as a potential substitute for the animalsourced anticoagulant drug. One step in the current process to prepare bioengineered heparin involves the conversion of N-sulfo heparosan, rich in→4)GlcNS(1→4) GlcA(1→sequences (where S is sulfo, GlcN is α-D-glucosamine, and GlcA is β-D-glucuronic acid), to a critical intermediate, rich in→4)GlcNS(1→4) IdoA2S(1→sequences (where S is sulfo and IdoA is α-L-iduronic acid), using 2-O-sulfotransferase (2-OST) and C5 epimerase (C 5 -epi). Until now, these heparan sulfate biosynthetic enzymes have been expressed in Escherichia coli grown in shake flask culture as fusion proteins. The current study is focused on the high cell density fedbatch cultivation of recombinant E. coli strains expressing both enzymes. We report the high Appl Biochem Biotechnol (2015) 
Introduction
Heparin is a critically important anticoagulant drug that is derived from animal tissue [1] . A recent contamination crisis [2] has led our laboratory to undertake the preparation of a bioengineered heparin to replace this animal-sourced drug [3] . Bioengineered heparin is prepared from heparosan, →4) N-acetyl-α-D-glucosamine (1 →4) ß-D-glucuronic acid (1→(→4) GlcNAc (1→4) GlcA(1→), the capsular polysaccharide of Escherichia coli K5 [4] that is chemically converted to N-sulfoheparosan and then enzymatically modified in a three-step process to obtain anticoagulant heparin [3] (Fig. 1) . The first enzymatic step in this process uses heparan sulfate biosynthetic enzymes expressed in E. coli as recombinant fusion proteins with maltose binding protein (MBP), 2-O-sulfotransferase (2-OST), and C5-epimerase (C 5 -epi), to convert N-sulfo heparosan into an intermediate polysaccharide rich in→4)GlcNS(1→4) IdoA2S(1→sequences (where S is sulfo and IdoA is α-L-iduronic acid). This critical step in bioengineered heparin preparation relies on the use of recombinant aryl sulfotransferase IV (AST-IV) to regenerate 3′-phospho adenosine-5′-phosphosulfate (PAPS) using p-nitrophenyl sulfate as a sacrificial sulfo donor [5] [6] [7] .
The generation of small quantities of bioengineered heparin, closely resembling animal-sourced heparin has been demonstrated [4] . In order to scale up this process, however, substantial quantities of E. coli expressed recombinant 2-OST and C 5 -epi are required. It is essential to produce the enzymes in high yield in stirred tank fermentor to Fig. 1 Three-step enzymatic synthesis of heparin from N-sulfoheparosan. a In the first step, N-sulfoheparosan is treated with 2-OST and C 5 -epi. b In the second step, 6-O-sulfotransferase isoforms 1 and 3 are used to prepare non-anticoagulant heparin. c In the third enzymatic step, 3-O-sulfotransferase isoform 1 is used to introduce the antithrombin (AT) pentasaccharide-binding site affording anticoagulant heparin. d PAPS, used as the sulfo donor in each step, forms PAP, which is recycled using aryl sulfotransferase IV (AST-IV) and p-nitrophenyl sulfate (PNPS) as a sacrificial sulfo donor, forming p-nitrophenol (PNP) which can be detected by its absorbance at 400 nm. The R at the top of panel D corresponds to the polysaccharide substrate scale up our chemoenzymatic processes for the production of bioengineered heparin. This study describes the scale-up of the production of these two enzymes from shake flask to stirred tank fermenter.
Materials and Methods

Materials
All media components, fermentation reagents, chemicals used for preparation of biomass extraction buffer, and chemicals and standards used in HPLC analysis were from SigmaAldrich (St. Louis, MO, USA). LB broth powder was purchased from BD Biosciences (San Jose, CA, USA). Kanamycin, ampicillin, tetracycline, chloramphenicol, and 1-thiogalactopyranoside (IPTG) were from Gold Biotechnology (St. Louis, MO, USA).
Bacterial Strain and Media
The recombinant E. coli Rosetta-gami B (DE3) cells (Novagen, Cambridge MA, USA) strain with the plasmid pMalc2x and the catalytic domain of Chinese hamster ovary 2-Osulfotransferase (Arg 51 -Asn356) was used to express 2-OST-MBP fusion product [8] . The same strain and plasmid with human C 5 -epimerase (E 53 -N 609 ) was used to express C 5 -epi-MBP fusion product [9] . Shake flask experiments were performed in a new formulated glucose and M9 minimal salts (64 g Na 2 HPO 4 -7H 2 O, 15 g KH 2 PO 4 , 2.5 g NaCl, 5.0 g NH 4 Cl)-based medium (200 ml/l of M9 salts, 2 ml/l of 1 M MgSO 4 , 20 ml/l of 20 % glucose, 100 μl/l of 1 M CaCl 2 , 20 g/l yeast extract, and 1 ml/l of a trace metal solution). Trace metal solution was made according to Matsui [10] (12. 5 mg/l), and kanamycin (50 mg/l) were always added to the media for both growth and propagation of the strain after filtered through 0.22 μm membrane with syringe. For C 5 -epi expression, 50 mg/ml chloramphenicol was added with all other three antibiotics.
Shake Flask Experiments
Transformed cells were incubated at 37°C on shaker with 220 rpm overnight to prepare cultures from stock bacteria. A 1-l media flask was inoculated with 2.5 % (v/v) of stock culture. When the fermentation reached an optical density at 600 nm (OD 600 ) of 0.6-0.8, the temperature was decreased to 22°C for 30 min. A 200-μl aliquot of 1 M IPTG was added to each 1 l of fermentation media for induction. For C 5 -epi expression, 200 mg/ml arabinose was used along with 0.2 mM IPTG. The culture was shaken for 16-18 h at 220 rpm at the reduced temperature of 22°C.
Fed-Batch Experiments
A 20-l bioreactor (Bio-Flo 4500, New Brunswick Scientific, Enfield, CT, USA), in situ sterilizable and equipped with pH and pO 2 probes (Mettler, Toledo, Switzerland) was used for fed-batch experiments. During growth, the fermentation parameters were controlled and data were collected by Biocommand A4 software (Eppendorf, Inc., Enfield, CT, USA).
For the 12-l fed-batch fermentation, 200 μl of glycerol stock bacteria were inoculated into a 250-ml shake flask containing 50 ml LB medium. After 12 h of cultivation in a shaker incubator (220 rpm) at 37°C, the entire pre-culture was aseptically transferred into a 2.5-l shake flask containing 500 ml LB medium and incubated under the same condition for 10 h. This was used to inoculate the 10-l fed-batch fermentation that took place in the 20-l bioreactor. Fed-batch experiments were performed at 37°C and pH of 7.0 in 10-l LB containing 4 g/l glycerol. The dissolved oxygen (DO) was set to 20 % and controlled by inlet airflow rate and agitation speed. The pH was set to 7.0 and controlled by acid pump for hydrochloric acid and base pump for ammonia water. After 6 h of batch phase, the culture was fed with a concentrated solution (450 g/l glucose, 45 g/l yeast extract, 4.5 g/l (NH 4 ) 2 SO 4 , and 4.5 g/l MgSO 4 ). In 2-OST fed-batch experiment, the culture was fed from 6 h to 10 h at a constant feeding rate of 5 ml/ min, from 12 h to 22 h at a constant feeding rate of 3 ml/min, from 24 to 26 h at a constant feeding rate of 1 ml/min. IPTG was added to a final concentration of 0.2 mM as soon as the OD 600 value reached 22.5. In the C 5 -epi fed-batch experiment, the culture was also constantly fed after 5 h with a feeding rate of 3 ml/min until 15 h and then from 19 to 25.5 h at a rate of 1.5 ml/min. C 5 -epi fed-batch experiment was induced at an OD 600 value of 22.4 at final concentrations of 0.2 mM IPTG and 1 mg/ml arabinose.
Bacterial growth was monitored at different time points by measuring the optical density at 600 nm (OD600) with a UVmini-1240 spectrophotometer (Shimadzu, Japan). The culture was diluted to the linear range. The cell pellet was collected by centrifugation at 3,501×g for 20 min at 4°C and frozen.
Biomass Extraction and Enzyme Purification
The pellet (20 g) was suspended in 100 ml of ice-cold loading buffer A (25 mM TrisHCl, pH 7.4, containing 500 mM NaCl) by vortexing, and cells were lysed on ice using a Q700 sonicator (Qsonica, Newtown, CT, USA) at power level 4.5 for 1 min (30 strokes, 1 s on and 1 s off). Sonication of the re-suspended cells was performed three times according to the program, taking 30 s break between each cycle. Cell debris was spun down at 20,000×g at 4°C for 30 min, and the supernatant was filtered through a 0.22-μm filter by using vacuum system into 50 ml tube cooled in an ice bath. The sample containing the expressed 2-OST or C 5 -epi was maintained on ice briefly prior to fast protein liquid chromatography (FPLC) purification.
The FPLC system was manually washed, without an attached column, for 5 min at a flow rate 5 ml/min with eluting buffer B (25 mM Tris-HCl, pH 7.5, containing 500 mM NaCl and 40 mM maltose monohydrate) and then washed for 5 min at flow rate 5 ml/min with loading buffer A. The amylose column was connected to the FPLC and the column, the sample was injected and the column was washed with buffer A for 10-15 min at a flow rate 2 ml/min and then washed with elution buffer B at a flow rate 2 ml/min for 5 min by manual operation. Purified enzyme was collected on a fraction collector with UV 280 detection and fractions containing the 6-OST peak were pooled together in a 50 ml tube. Glycerol 10 vol.% was added to the enzyme before it was stored at −80°C.
SDS-PAGE and Protein Concentration Analysis
Protein concentration was determined with Nanodrop 3300 (Thermo Fisher Scientific Inc., Wilmington, DE, USA). SDS-PAGE protein analysis was performed in a MiniProtean Tetra system (BIORAD, Hercules, CA, USA), by loading 30 μl of 1:1 (v:v) boiled protein solution and dye buffer on a 4-20 % precast gel (Mini protean TGX gels, BIORAD) and running in a Tris, glycine, and SDS buffer (10× Tris/glycine/SDS buffer, BIORAD) at 100 V for 45 min. A 250-to 10-kDa protein standard (Precision Plus Protein Kaleidoscope, BIORAD) was used as ladder. Gels were washed with tap water for 30 min and then stained by soaking for 5 h in Coomassie blue solution (Gel Code Blue Safe Protein Stain, Thermo Fisher Scientific).
Activity Assay
The 2-OST activity assay was performed as previously described with some modification [6, 7, 9] . The activity was analyzed by incubating 50 μg of purified 2-OST with 25 μg of N-sulfoheparosan, 25 μg of AST-IV, 0.5 μM para-nitrophenyl sulfate (PNPS), and 2 μg PAPS in 250 μl system with supplement of 50 mM MES buffer pH 7.0. 10 mM MnCl 2 , 5 mM MgCl 2 , and 1 % Triton X-100 (pH 7). For assaying the activity of C 5 -epi, in addition to 50 μg purified C 5 -epi, 50 μg purified 2-OST was also added to the assay system mentioned above [11] . The assays were conducted in transparent, 96-well plates purchased from Greiner Bio-One (Monroe, NC, USA). The plates were incubated at 37°C in SpectraMax plate reader (Molecular Devices, Sunnyvale, CA, USA). A kinetic model was used to measure the absorbance at 400 nm/min over 1 h. The enzyme activity was calculated using the following equation:
*1000
Abs t2 and Abs t1 are the absorbance at 400 nm at t 2 min and t 1 min, respectively. The time range was chosen between a linear segment of the plot. ε 0 is the extinction coefficient (10.5×10 −3 ), RT is the reaction time (min), [Enz] 1/10 is the concentration of the assayed enzyme divided by 10. One unit of the specific activity per mg of protein corresponds to the enzyme producing 1 nmol PNP/min at 37°C.
Mass Analysis
The disaccharide analysis was carried out as reported previously [12] . Heparin lyase 1, 2, and 3 (10 mU each) in 5 μl of 25 mM Tris, 500 mM NaCl, 300 mM imidazole buffer (pH 7.4) were added to 10 μg of 2-OST or C 5 -epi treated sample in 100 μl of distilled water and incubated at 35°C for 10 h to degraded the hydrolyzed sample completely. The products were recovered by centrifugal filtration using a YM-10 micro-concentrator, and the disaccharides were recovered in the flow-through and freeze-dried. The digested disaccharides were dissolved in water to concentration of 50-100 ng/2 μl for liquid chromatography (LC)-mass spectrometric (MS) analysis.
LC-MS analyses were performed on an Agilent 1200 LC/MSD instrument (Agilent Technologies, Inc. Wilmington, DE) equipped with a 6,300 ion trap and a binary pump followed by a UV detector equipped with a high-pressure cell. The column used was a Poroshell 120 C18 column (2.1×100 mm, 2.7 μm, Agilent, USA). Eluent A was water/ acetonitrile (85:15) v/v, and eluent B was water/acetonitrile (35:65) v/v. Both eluents contained 12 mM tributylamine (TrBA) and 38 mM ammonium acetate with pH adjusted to 6.5 with acetic acid. The gradient of solution A for 5 min followed by a linear gradient from 5 to 15 min (0-40 % solution B) was used at flow rate of 150 μl/min.
HPLC Analysis
Concentrations of glucose and acetic acid in the medium during the fermentation were measured by HPLC as previously described [13] .
Results
Culture Conditions of Shake Flask Experiments
Shake flask experiments were performed to investigate the medium and culture and induction conditions that are suitable for fed-batch expression. The batch cultures of recombinant E. coli harboring pMAL-c2X -2-OST and pMAL-c2X-C 5 -epi usually were carried out in LB medium [8, 11] . In order to identify medium conditions suitable for batch fed fermentation, we investigated the effect of different media components on the expression of 2-OST and C 5 -epi. A new M9 salt and glucose-based medium was identified that can be used to express both of these enzymes. The cultures grown until OD 600 = 0.6 were induced once using IPTG at 0.2 mM for 2-OST, and IPTG plus 200 mg/ml of arabinose for C 5 -epi. The results showed that the specific activity of 2-OST and C 5 -epi were 1.7±0.1 and 1.15±0.05 U, respectively (Fig. 2) .
High Cell Density Cultivation
In most processes, the aim is to reach highest possible cell densities in a short time under aerobic conditions to meet the demand of large-scale bioengineering heparin biosynthesis. For the fed-batch fermentation of 2-OST, the maximum cell density was 5.5 g cdw /l ( Table 1 ). The concentration of purified enzyme was 167 mg/l. The productivity was 6.0 mg/l-h, and the final specific activity was 0.54±0.01 nmol/min mg. After 20 h, the percent conversion of NS2S was 63.4 %. Acetic acid, which was produced as a byproduct during batch mode, is generally produced at a high specific growth rate when there is excess carbon source or oxygen-limited conditions [14] . In this experiment, acetic acid accumulated up to 15.1 g/l in the cell-free culture medium; therefore, a constant feeding rate did not meet the demand of exponential cell growth, and the glucose concentration was changed over a wide range (Fig. 3) . For the fed-batch fermentation of C 5 -epi, feeding was initiated after acetic acid was consumed. The maximum cell density achieved was 5.9 g cdw /l. The concentration of purified enzyme was 65.3 mg/l. The productivity was 2.2 mg/l-h, and the final specific activity was 1.78±0.05 nmol/ min mg ( Table 1, Fig. 4) . After 20 h, NS2S conversion was 70 %. As mentioned above, the acetic acid concentration was high, which suggested that the feeding model should be optimized for higher cell density and/or higher enzyme production.
The 2-OST and C 5 -epi were purified using an amylose column. There were no more than four bands observed in SDS-PAGE analysis with the most intense band corresponding to each of the target proteins (Fig. 3 ). These results demonstrate that the MBP tag of these recombinant proteins represents and efficient means for their purification.
Discussion
The chemoenzymatic preparation of a bioengineered heparin relies on three enzymatic steps, the first and most difficult step requires the extensive epimerization of GlcA to IdoA by C 5 -epiand its subsequent sulfation with 2-OST to afford IdA2S. Since the epimerization reaction catalyzed byC 5 -epi is reversible, 2-OST must be present to quickly trap IdoA as IdoA2S in order to obtain a polysaccharide product, such as heparin, which contains up to 80-90 % IdoA2S residues. Thus, there is a need for larger quantities of active C 5 -epi and 2-OST than can be produced in shake flask culture. As part of our efforts to scale-up the production of these enzymes, we turned to fed-batch stirred tank fermenters. Unfortunately, initial attempts to prepare these critical enzymes resulted in either low levels of these enzymes or inactive enzymes.
Preventing the accumulation of toxic levels of acetic acid is a major task to achieve high cell concentrations in the bioreactor. The accumulation of acetic acid in the media may have toxicity effects on the cells in the culture. The primary factor contributing to the toxicity of acetic acid is its ability to diffuse across E. coli cellular membranes. The diffusing acetic acid or other organic acids entering into the cytoplasm will disrupt the pH and anion pool of the cytoplasm. The resulting increase in internal acidity can affect the integrity of purine bases and result in denaturing of essential enzymes inside the cell, both of which negatively affect cell viability and enzyme expression. The specific growth rate of E. coli K12 batch cultured in the fermenter decreased from 15 to 5 g/l as the acetic acid concentration increased [14] . Growth-inhibiting acidic by-products of incomplete substrate oxidation, such as acetic acid, are produced in response to oxygen limitation or excess carbon. The formation of acetic acid and subsequent growth inhibition can be avoided by limiting the amount of carbon source in the culture media via an exponential feeding strategy [15] or by controlling the dissolved oxygen level [16] . Although active 2-OST and C 5 -epi were obtained, the fed-batch fermentations were not optimized, cell densities achieved were not sufficiently high, and the relationship between the growth rate and enzyme expression is unclear. Additional work remains to be performed before this process step can be taken to pilot-scale production.
Conclusions
This study demonstrates the high-density cultivation of recombinant E. coli strains for the high productivity expression of recombinant 2-OST and C 5 -epi. These enzymes are critically important in the first enzymatic step in the chemoenzymatic preparation of bioengineered heparins.
